Ntchapda Fidèle, Abakar Djedouboum, Kom Blaise, Nana Paulin, Hamadjida Adjia, Dimo Théophile
Department of Biological Sciences, Faculty of Science, University of Ngaoundéré, Cameroon.
Department of Chemistry, Faculty of Science, University of Ngaoundéré, Cameroon.
J Intercult Ethnopharmacol. 2014 Oct-Dec;3(4):206-13. doi: 10.5455/jice.20140913021547. Epub 2014 Sep 27.
Ficus glumosa Del (Moraceae), a plant used in traditional medicine in Cameroon, Senegal, and East Africa for the treatment of edema, hemorrhoid, cardiovascular diseases especially hypertension.
The present study evaluated the potential toxicity of the aqueous extract of the leaves of F.glumosa in acute and sub-chronic administration in rodents.
Acute toxicity was evaluated on 3 months old mice of both sexes and weighing 20-30 g. A single dose (2-12 g/kg) of F. glumosa was administered orally to mice. Animal behavior, adverse effects, and mortality were determined for 14 days. In sub-chronic toxicity studied in both sexes of 9 weeks old rats and weighing 100-120 g at the start of the experiment, animals were treated orally with a daily dose of 300, 600 and 1200 mg/kg of the aqueous extract of the leaves of F. glumosa for 6 weeks. The body weight change, food, and water consumption, were determined throughout the experimental period, while the relative organ weights, the hematological and biochemical parameters of blood and urine, as well as the histology of tissues kidney and liver, were recorded at the end of the experiment.
For acute treatment, no dose used induced critical behavioral changes or death. In sub-chronic treatment, daily oral administration of F. glumosa at the dose of 300, 600, and 1200 mg/kg resulted in a significant increase in body weight relative to food and water consumption in the last week of treatment. The relative organ weights were not affected by treatment. No hematological changes were observed except the significant increase in platelets. Aspartate aminotransferase, alanine transaminase, alkaline phosphatase, total protein, increased while the total cholesterol, triacylglycerol, conjugated bilirubin, and total bilirubin significantly decreased. Index of renal function showed a decrease of creatinine, urea, uric acid and Na(+), Cl(-) and Ca(2+), and inorganic phosphate. The histology of liver and kidney showed no significant alteration of tissue.
These observations support the traditional use of F. glumosa in the treatment of hypertension. These results have shown that F. glumosa has a safety margin for therapeutic use.
毛叶榕(桑科),一种在喀麦隆、塞内加尔和东非用于传统医学治疗水肿、痔疮、心血管疾病尤其是高血压的植物。
本研究评估了毛叶榕叶水提取物在啮齿动物急性和亚慢性给药中的潜在毒性。
对3月龄、体重20 - 30 g的雌雄小鼠进行急性毒性评估。给小鼠口服单剂量(2 - 12 g/kg)的毛叶榕。在14天内观察动物行为、不良反应和死亡率。在亚慢性毒性研究中,选用9周龄、实验开始时体重100 - 120 g的雌雄大鼠,每日口服剂量为300、600和1200 mg/kg的毛叶榕叶水提取物,持续6周。在整个实验期间测定体重变化、食物和水的消耗量,在实验结束时记录相对器官重量、血液和尿液的血液学及生化参数,以及肾脏和肝脏组织的组织学情况。
急性治疗时,所用剂量均未引起严重行为改变或死亡。在亚慢性治疗中,在治疗的最后一周,每日口服300、600和1200 mg/kg剂量的毛叶榕导致体重相对于食物和水的消耗量显著增加。相对器官重量未受治疗影响。除血小板显著增加外,未观察到血液学变化。天冬氨酸转氨酶、丙氨酸转氨酶、碱性磷酸酶、总蛋白升高,而总胆固醇、三酰甘油、结合胆红素和总胆红素显著降低。肾功能指标显示肌酐、尿素、尿酸以及钠(Na⁺)、氯(Cl⁻)、钙(Ca²⁺)和无机磷酸盐降低。肝脏和肾脏的组织学检查显示组织无明显改变。
这些观察结果支持毛叶榕在治疗高血压方面的传统用途。这些结果表明毛叶榕在治疗使用上有安全范围。